Nuvectis Pharma, Inc. (NVCT)

NCM – Real Time Price. Currency in USD

19.45

+0.04 (0.21%)

Market open: Aug 12, 2026, 3:01 PM EDT

19.41

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

Gross Profit

Operating expenses (excl. COGS)

-28M

-20M

-23M

-19M

Operating Income

-28M

-20M

-23M

-19M

Non-operating income, total

847K

637K

149K

Pretax income

-26M

-19M

-22M

-19M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

-2M

Net income before discontinued operations

-29M

-19M

-22M

-19M

Discontinued operations

Net income

-29M

-19M

-22M

-19M

Dilution adjustment

Preferred dividends

Nuvectis Pharma, Inc. (NVCT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Nuvectis Pharma, Inc. (NVCT)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Nuvectis Pharma, Inc. (NVCT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Nuvectis Pharma, Inc. (NVCT)

Income Statement (Annual)

Income Statement (Annual)